|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:appointed_by
|
oral route
|
|
gptkbp:approves
|
gptkb:1987
gptkb:FDA
|
|
gptkbp:brand
|
Prinivil
Zestril
|
|
gptkbp:class
|
gptkb:CEO
|
|
gptkbp:clinical_trial
|
Phase IV
Phase III
|
|
gptkbp:contraindication
|
pregnancy
angioedema history
|
|
gptkbp:discovered_by
|
gptkb:Merck_&_Co.
|
|
gptkbp:dosage_form
|
10 mg
5 mg
20 mg
2.5 mg
40 mg
|
|
gptkbp:duration
|
long-term
|
|
gptkbp:excretion
|
kidneys
|
|
gptkbp:formulation
|
gptkb:software_framework
gptkb:tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Lisinopril
|
|
gptkbp:ingredients
|
C21 H31 N3 O5
|
|
gptkbp:interacts_with
|
lithium
diuretics
potassium supplements
NSAI Ds
|
|
gptkbp:is_available_on
|
generic
|
|
gptkbp:is_used_for
|
hypertension
heart failure
diabetic nephropathy
|
|
gptkbp:lifespan
|
12 hours
|
|
gptkbp:marketed_as
|
gptkb:Australia
gptkb:India
gptkb:UK
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:research_areas
|
cardiology
endocrinology
internal medicine
pharmacology
nephrology
|
|
gptkbp:side_effect
|
dizziness
fatigue
headache
cough
hyperkalemia
|
|
gptkbp:treatment
|
chronic
|
|
gptkbp:type_of
|
83915-83-7
|
|
gptkbp:bfsParent
|
gptkb:ACE_inhibitors
|
|
gptkbp:bfsLayer
|
5
|